Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / UNIT 09/16/2030
-
Total 13F shares
-
46,104,933
-
Share change
-
+45,747,831
-
Total reported value
-
$458,521,662
-
Price per share
-
$9.94
-
Number of holders
-
75
-
Value change
-
+$454,970,231
-
Number of buys
-
74
Institutional Holders of Drugs Made In America Acquisition II Corp. - UNIT 09/16/2030 (DMIIU) as of Q3 2025
As of 30 Sep 2025,
Drugs Made In America Acquisition II Corp. - UNIT 09/16/2030 (DMIIU) was held by
75 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
46,104,933 shares.
The largest 10 holders included
MMCAP International Inc. SPC, Magnetar Financial LLC, GLAZER CAPITAL, LLC, HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND, MILLENNIUM MANAGEMENT LLC, LMR Partners LLP, Hudson Bay Capital Management LP, First Trust Capital Management L.P., TENOR CAPITAL MANAGEMENT Co., L.P., and Polar Asset Management Partners Inc..
This page lists
75
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.